U.S. Renal Care, Inc. Completes Acquisition of Dialysis Corporation of America Company to serve approximately 5,500 patients through 120 dialysis programs in 9 states
PLANO, Texas and JONESBORO, Ark.,June 7 /PRNewswire/ -- U.S. Renal Care, Inc. (USRC), a leading privately-held provider of outpatient dialysis services, today announced that it has completed its $110.25 million acquisition of Dialysis Corporation of America, Inc. (Nasdaq: DCAI) (DCA), a leading provider of outpatient kidney dialysis services. With this acquisition, USRC will provide dialysis services to approximately 5,500 patients and operate 84 dialysis centers, home and specialty hospital dialysis programs and facilities in nine states: Arkansas, Georgia, Maryland, New Jersey, Ohio, Pennsylvania, South Carolina, Texas, and Virginia.
"This transaction represents a major milestone for our organization as we transition from being a regional provider to a national leader," said Chris Brengard, Chief Executive Officer of U.S. Renal Care. "DCA is a top tier company in our industry and from the start of this transaction we have been excited about the many benefits of combining our companies. We look forward to working with the DCA physicians, employees and team leaders to make the transition to a unified company seamless."
"By broadening our geographic footprint, we are extending our high-quality dialysis care to thousands more patients suffering from chronic and acute renal disease," said Brengard. "As we continue to provide best-in-class patient care, we will look for additional opportunities to strategically grow our business and improve our programs."
The acquisition of DCA is the latest in a series of achievements for USRC. During the past five years, USRC has raised over $75 million in equity capital, including $25 million in new equity in 2010 to complete its tender offer for DCA. Since 2005, USRC's funding has come from the Company's management and several leading investment firms including SV Life Sciences, Cressey & Company, Salix Ventures, and Select Capital Ventures.
"I am very proud of the business we built at DCA," said Thomas K. Langbein, former Chairman of the Board of DCA. "I thank our shareholders who can be proud to have been part of DCA's success. I thank our employees and our physicians for contributing to our growth and success. Given the compatibilities of the two companies, the integration of DCA with USRC will be a smooth and efficient transition."
With shared values and a mission to provide best-in-class renal care, USRC and DCA are well-matched. "As a company, we put the needs of our patients first," said Stephen Everett, former President and CEO of DCA. "This philosophy has fueled our growth. I am grateful to the physicians and employees of DCA who ensured the company never lost sight of our patient-centric values. USRC is the perfect match for DCA's culture, philosophy, and commitment to exemplary patient care. There is no doubt that the future is bright for USRC, our combined physicians and staff."
USRC was founded in Jonesboro, Arkansas in 2000 by Chris Brengard and is recognized as a leader in establishing joint ventures with nephrologists for the operation outpatient treatment centers for individuals suffering from chronic kidney failure. In 2006, the company moved its headquarters to Dallas, Texas, though its executive offices and certain other key business functions still operate in Arkansas.
About U.S. Renal Care, Inc.
Founded in 2000 by an experienced team of healthcare executives, U.S. Renal Care, Inc. works in partnership with nephrologists to develop, acquire, and operate outpatient treatment centers for persons suffering from chronic kidney failure, also known as End Stage Renal Disease. The company provides patients with their choice of a full range of quality in-center, acute or at-home hemodialysis and peritoneal dialysis services. U.S. Renal Care operates dialysis programs in Arkansas, Texas, Georgia, Maryland, New Jersey, Ohio, Pennsylvania, South Carolina, and Virginia. For more information on U.S. Renal Care, Inc. visit www.usrenalcare.com.
New Feature from Hemodialysis.com: Hemodialysis or Chronic Kidney Disease Abstract of the Week
Zasuwa G, Frinak S, Besarab A, Peterson E, Yee J.
Division of Nephrology and Hypertension, Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan.
Although monitoring of vascular accesses by physical examination is nearly as sensitive as surveillance measurements by vascular access pressure when performed by examiners, the frequency of examinations is limited by time.
We developed intravascular access pressure surveillance as a surrogate to physical examination. Using real-time data from hemodialysis machines, we derived intravascular access pressure ratios for each dialytic procedure. An automated, noninvasive surveillance algorithm that generated a "warning" list of patients at risk for thrombosis was formulated.
We hypothesized that this algorithm would reduce access thrombosis frequency. We designed a study comparing thrombosis rates during a baseline 6-month interval to three subsequent 6-month periods of active surveillance.
Referrals for interventions during this 18-month period were based on persistently abnormal elevated vascular access pressure ratio tests (VAPRT) >0.55.
Thrombosis rates declined progressively for arteriovenous grafts (AVG) during the intervention period compared with the baseline period.
Arteriovenous fistula (AVF) thrombosis rates decreased during postintervention months 13-18 during employment of the VAPRT.
We conclude that use of VAPRT can reduce thrombosis rates in vascular accesses, and the magnitude of the effect is larger and more consistent in arteriovenous grafts (AVGs) than autologous AVFs.
Hemodialysis | Kidney Disease | Dialysis Resources and Educational Materials
100 Q&A About Kidney Disease and Hypertension
Raymond R. Townsend, MD
High blood pressure is one of the leading causes of kidney failure. Each year, high blood pressure causes more than 25,000 new cases of kidney failure in the United States. 100 Questions & Answers About Kidney Disease and Hypertension offers authoritative, up-to-date, practical answers about kidney disease, end-stage renal disease, transplants, and dialysis. The book is an invaluable resource for anyone coping with the physical and emotional turmoil of this condition.
Handbook of Dialysis Therapy
Here's an in-depth, quick-reference, problem-solving resource for those involved in the care of dialysis patients. More than 120 world-class authorities discuss dialysis techniques, mechanical considerations, and complications related to various diseases for both pediatric and adult patients. Selected annotated references and excellent cross-referencing between chapters help you find answers fast, and more than 100 photos, drawings, charts, and tables, mostly in color, clarify complex topics. Providing practical, immediately useful guidelines that can be applied directly to patient care, this book is a "must-have" for all dialysis caregivers.
Certified Hemodialysis Technologist/Technician Exam Secrets Study Guide: CHT Test Review for the Certified Hemodialysis Technologist/Technician Exam
Certified Hemodialysis Technologist/Technician Exam Secrets helps you ace the Certified Hemodialysis Technologist/Technician Exam, without weeks and months of endless studying. Our comprehensive Certified Hemodialysis Technologist/Technician Exam Secrets study guide is written by our exam experts.....
Dialysis and Hemodialysis Book and Descriptions from Amazon.com
Please visit the Hemodialysis.com Google Ad Sponsors
The information on Hemodialysis is for informational purposes only and is not intended as specific medical advice or to be a substitute for medical advice from your physician or health care provider. Please check with a physician if you need a diagnosis and/or for treatments as well as information regarding your specific condition.
Please read Medical Disclaimer as term of condition for usage of this website.
If you are experiencing urgent medical conditions, call 9-1-1
Copyright 2010 EminentDomains.com®. All Rights Reserved.
Our Success is Linked to Your Success®